A Comprehensive Study of the Issue of Fake Drugs in the Indian Market

India has grown to be a significant manufacturer and exporter of pharmaceuticals; the quality of these products and the regulatory environment in the nation are important to both India and the rest of the world. This review's goal was to investigate how blockchain technology might be used to provide a fresh defense against counterfeit drugs. By establishing a transparent and secure health data network, the proposed method aims to efficiently identify and stop the distribution and use of fake medications.Numerous factors, such as the high cost of pharmaceuticals, limited access to healthcare, and a general lack of public understanding, have been connected to the sale of fake and counterfeit medications in India. A report indicates that between 12 and 25 percent of the medications given in India are thought to be counterfeit. India is one of the world's leading producers of fake and counterfeit pharmaceuticals, and it also has a considerable market for them. Drug counterfeiting must be actively opposed since it poses a harm to society. Although laws, regulatory monitoring, and recurring sample testing to confirm the veracity of label claims are required to enforce country-specific requirements to detect medicine counterfeiting, these regulations vary. Drug counterfeiting has become a worldwide problem. It is impossible for any country to prevent the pharmaceutical sector from selling counterfeit drugs.